CNS abnormalities in patients with familial amyloidosis, Finnish type (FAF)

References

• Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. Ann Clin Res 1969; 1: 314–324
   PubMedGoogle Scholar
• Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet 1973; 4: 173–185
   PubMed Web of Science ®Google Scholar
• Ghiso J, Haltia M, Prelli F, Novello J, Frangione B. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 1990; 272: 827–830
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Baumann M. Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1990; 1096: 84–86
   PubMed Web of Science ®Google Scholar
• Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990; 172: 1865–1867
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Kere J, Tolvanen R, de la Chapelle A. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett 1990; 276: 75–77
   PubMed Web of Science ®Google Scholar
• Paunio T, Kiuru S, Hongell V, Mustonen E, Syvänen A C, Bengtström M, Palo J, Peltonen L. Solid-phase minisequencing test reveals Asp187-<Asn(G654-<A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992; 13: 237–239
   PubMed Web of Science ®Google Scholar
• Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation-at codon 187- in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet 1992; 42: 357–359
   PubMed Web of Science ®Google Scholar
• Gorevic P, Munoz P, Gorgone G, Purcell J J, Jr, Rodrigues M, Ghiso J, Levy E, Haltia M, Frangione B. Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. New Engl J Med 1991; 325: 1780–1785
   PubMed Web of Science ®Google Scholar
• de la Chapelle A, Kere J, Sack G H, Jr, Tolvanen R, Maury C PJ. Familial amyloidosis, Finnish type: G654-< A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1992; 13: 898–901
   PubMed Web of Science ®Google Scholar
• Sunada Y, Shimizu T, Nakase H, Ohta S, Asaoka T, Amano S, Sawa M, Kagawa Y, Kanazawa I, Mannen T. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neural 1993; 33: 57–62
   PubMed Web of Science ®Google Scholar
• de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury C PJ, Kere J. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nature Genet 1992; 2: 157–160
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Nurmiaho-Lassila E L. Creation of amyloid fibrils from mutant Asn 187 gelsolin peptides. Biochem Biophys Res Commun 1992; 183: 227–231
   PubMed Web of Science ®Google Scholar
• Meretoja J, Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report of three cases. Acta Path Microbiol Scand Section A 1971; 79: 432–440
   PubMedGoogle Scholar
• Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand 1992; 86: 346–353
   PubMed Web of Science ®Google Scholar
• Kiuru S, Seppålåinen A M. Neuropathy in familial amyloidosis, Finnish type (FAF): electrophysiological studies. Muscle Nerve 1994; 17: 299–304
   PubMed Web of Science ®Google Scholar
• Kiuru S, Matikainen E, Kupari M, Haltia M, Palo J. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci 1994, in press
   Google Scholar
• Maury C PJ, Kere J, Tolvanen R, de la Chapelle A. Homozygosity for the Asn 187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 1992; 13: 902–903
   PubMed Web of Science ®Google Scholar
• Haltia M, Ghiso J, Wisniewski T, Kiuru S, Miller D, Frangione B. Gelsolin variant and β-amyloid cooccur in a case of Alzheimer's with Lewy bodies. Neurobiol Aging 1991; 12: 313–316
   PubMedGoogle Scholar
• Gudmundsson G, Hallgrimsson J, Jonasson T, Bjarnason O. Hereditary cerebral hemorrhage with amyloidosis. Brain 1972; 95: 387–404
   PubMed Web of Science ®Google Scholar
• Wattendorff A R, Bots G TAM, Went L N, Endtz L J. Familial cerebral amyloid angiopathy presenting as recurrent cerebral hemorrhage. J Neurol Sci 1982; 55: 121–135
   PubMed Web of Science ®Google Scholar
• Ganrot K, Laurell C B. Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem 1974; 20: 571–573
   PubMed Web of Science ®Google Scholar
• Tienari P, Salonen O, Wikström J, Valanne L, Palo J. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 1992; 55: 883–886
   PubMed Web of Science ®Google Scholar
• Suomalainen A, Majander A, Haltia M, Somer H, Lönnqvist J, Savontaus M L, Peltonen L. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992; 90: 61–66
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler adult intelligence scale Manual. Psychological Corporation, New York 1955
   Google Scholar
• Wechsler D. WAIS kasikirja, Wechslerin aikuisten alykkyysasteikko. Psykologien kustannus Oy, Helsinki 1970
   Google Scholar
• Wechsler D. A standardized memory scale for clinical use. J Psychol 1945; 19: 87–95
   Web of Science ®Google Scholar
• Wechsler D. Wechslerin muistitaulukko. Psykologien kustannus Oy, Helsinki 1975
   Google Scholar
• Christensen A L. Luria's Neuropsychological Investigation. Munksgaard, Copenhagen 1974
   Google Scholar
• Erkinjuntti T, Laaksonen R, Sulkava R, Syrjalainen R, Palo J. Neuropsychological differentation between normal aging, Alzheimer's disease and vascular dementia. Acta Neurol Scand 1986; 74: 393–403
   PubMed Web of Science ®Google Scholar
• Marvel G, Golden C, Hammeke T, Purisch A, Osmon D. Relationship of age and education to performance on a standardized version of Luria's neuropsychological tests in different patient populations. Intern J Neuroscience 1979; 9: 63–70
   PubMed Web of Science ®Google Scholar
• Haan J, Lanser J BK, Zijderveld I, van der Does I GF, Roos R AC. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. Arch Neurol 1990; 47: 965–967
   PubMedGoogle Scholar
• Lezak M D. Neuropsychological Assessment. Oxford University Press, New York 1983; 429–432
   Google Scholar
• Beck A T, Beck R W. Screening depressed patients in family practice. Postgrad Med 1972; 52: 81–85
   PubMed Web of Science ®Google Scholar
• Bradley W G, Waluch V, Brant-Zawadzki M, Yadley R A, Wycoff D R. Patchy, periventricular white matter lesion in the elderly: a common observation during NMR imaging. Noninvasive Med Imaging 1984; 1: 35–41
   Google Scholar
• Gerard G G, Weisberg L A. MRI periventricular lesions in adults. Neurology 1986; 36: 998–1001
   PubMed Web of Science ®Google Scholar
• Awad I A, Spetzler R F, Hodak J A, Awad C A, Carey R. Incidental subcortical lesions on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986; 17: 1084–1089
   PubMed Web of Science ®Google Scholar
• Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985; 18: 54–59
   PubMed Web of Science ®Google Scholar
• Loes D, Biller J, Yuh W, Hart M N, Godersky J C, Adams H P, Jr, Keefauver S P, Tranel D. Leukoencephalopathy in cerebral amyloid angiopathy: MR imaging in four cases. AJNR 1990; 11: 485–488
   PubMed Web of Science ®Google Scholar
• Scheltens P, Barkhof F, Leys D, Pruvo J P, Nauta J JP, Vermersch P, Steinling M, Valk J. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993; 114: 7–12
   PubMed Web of Science ®Google Scholar
• Luria A R. Higher Cortical Functions in Man. Tavistock publications, London 1966; 233–250
   Google Scholar
• Benton A. Differential behavioural effects in frontal lobe disease. Neuropsychologia 1968; 6: 53–60
   Web of Science ®Google Scholar
• Lezak M D. Neuropsychological Assessment. Oxford University Press, New York 1983; 310–311
   Google Scholar
• Botwinick J. Neuropsychology of aging. Handbook of clinical Neuropsychology, S Filskov, T Boll. John Wiley & Sons Inc, New York 1981; 135–171
   Google Scholar
• Yin H L, Stossel T P. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 1979; 281: 583–586
   PubMed Web of Science ®Google Scholar
• Yin H L, Albrecht J H, Fattoum A. Identification of gelsolin, a Ca2+-dependent regulatory protein of actin gel-sol transformation, and its intracellular distribution in a variety of cells and tissues. J Cell Biol 1981; 91: 901–906
   PubMedGoogle Scholar
• Verkhovsky A B, Surgucheva I G, Gelfand V I. Phalloidin and tropomysin do not prevent actin filament shortening by the 90 kD protein-actin complex from brain. Biochem Biophys Res Commun 1984; 123: 596–603
   Google Scholar
• Forscher P. Calcium and polyphosphoinositide control of cytoskeletal dynamics. Trends Neurosci 1989; 12: 468–474
   PubMed Web of Science ®Google Scholar
• Yin H, Kwiatkowski D J, Mole J E, Cole F S. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 1984; 259: 5271–5276
   PubMed Web of Science ®Google Scholar
• Paunio T, Kiuru S, Karonen S L, Palo J, Peltonen L. Quantification of serum and CSF gelsolin in familial amyloidosis, Finnish type. Amyloid: Int J Exp Clin Invest 1994; 1: 80–89
   Web of Science ®Google Scholar